Cantel Medical Appoints Jorgen B. Hansen As Executive Vice
President And Chief Operating Officer
LITTLE FALLS, N.J.,
Nov. 7, 2012 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE: CMN) announced today the
appointment of Jorgen B. Hansen as
its Executive Vice President and Chief Operating Officer. Mr.
Hansen will join Cantel on November
15 and will be responsible for the operations of all Cantel
subsidiaries.
Mr. Hansen has been in global leadership positions with
increasing responsibility within the healthcare and medical devices
industry for over fifteen years. Most recently, he was Senior
Vice President, Global Marketing, Business Development, Science and
Innovation for ConvaTec Corp. Prior to that, he held
leadership roles in Asia and
Europe ranging from General
Manager, Division head and Senior Vice President of Global
Operations for Coloplast A/S. Mr. Hansen received his BS Degree in
Mechanical Engineering from Copenhagen Technical University, and an
International Commerce degree from the Copenhagen Business School
in Denmark.
Mr. Andrew Krakauer, President
and CEO of Cantel Medical Corp said, "With his extensive background
in healthcare and experience in sales and marketing, manufacturing,
business development, new product development, acquisitions and
international business, Jorgen is the ideal person to fill the
newly created and challenging position of Chief Operating Officer.
He will play a major role in the planning and implementation of
strategic growth plans for the Company."
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE:
CMN) is a leading provider of infection prevention and control
products in the healthcare market. Our products include water
purification equipment, sterilants, disinfectants and cleaners,
specialized medical device reprocessing systems for endoscopy and
renal dialysis, disposable infection control products primarily for
dental and GI endoscopy markets, dialysate concentrates and other
dialysis supplies, hollow fiber membrane filtration and separation
products for medical and non-medical applications, and specialty
packaging for infectious and biological specimens. We also provide
technical maintenance for our products and offer compliance
training services for the transport of infectious and biological
specimens.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
SOURCE Cantel Medical Corp.